[Acetylsalicylic acid in patients with diabetes for the primary prevention of cardiovascular disease].
作者信息
Hovens M M C, Cannegieter S C
出版信息
Ned Tijdschr Geneeskd. 2004 Oct 16;148(42):2097; author reply 2097-8.
PMID:15532335
Abstract
摘要
相似文献
1
[Acetylsalicylic acid in patients with diabetes for the primary prevention of cardiovascular disease].
Ned Tijdschr Geneeskd. 2004 Oct 16;148(42):2097; author reply 2097-8.
2
[Acetylsalicylic acid for the primary prevention of cardiovascular disease in diabetic patients].
Ned Tijdschr Geneeskd. 2004 Jul 24;148(30):1481-5.
3
[Acetylsalicylic acid in patients with diabetes mellitus: can be used for secondary but not primary prevention of cardiovascular events].
Ned Tijdschr Geneeskd. 2009;153:A109.
4
Use of antiplatelet therapy in a diabetic outpatient service of a large urban public hospital.
Nutr Metab Cardiovasc Dis. 2005 Feb;15(1):42-6. doi: 10.1016/j.numecd.2004.04.001.
5
[Aspirin use in patients with diabetes mellitus].
Med Clin (Barc). 2004 Jul 10;123(6):237; author reply 239.
6
[Should we treat all diabetic patients with aspirin in primary prevention?].
Rev Med Suisse. 2005 Jun 1;1(22):1500-4.
7
[Acetylsalicylic acid and diabetes mellitus].
Acta Med Port. 2002 May-Jun;15(3):199-202.
8
[Primary prevention of cardiovascular diseases with acetylsalicylic acid].
Dtsch Med Wochenschr. 2005 Dec 9;130(49):2847-52. doi: 10.1055/s-2005-923318.
9
The benefit of aspirin therapy in type 2 diabetes: what is the evidence?
Int J Cardiol. 2008 Sep 26;129(2):172-9. doi: 10.1016/j.ijcard.2008.01.030. Epub 2008 May 20.
10
[The role of aspirin in the primary prevention of cardiovascular disease].
Rev Med Suisse. 2006 Mar 8;2(56):646-51.
Zotero 插件